145 related articles for article (PubMed ID: 32805516)
1. Vitamin D receptor and cellular retinol-binding protein-1 immunohistochemical expression in normal, hyperplastic and neoplastic endometrium: Possible diagnostic and therapeutic implications.
Badary DM; Abou-Taleb H
Ann Diagn Pathol; 2020 Oct; 48():151569. PubMed ID: 32805516
[TBL] [Abstract][Full Text] [Related]
2. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
Orlandi A; Ferlosio A; Ciucci A; Francesconi A; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
Mod Pathol; 2006 Jun; 19(6):797-803. PubMed ID: 16575402
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract][Full Text] [Related]
4. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immunohistochemical expression of stem cell markers (NANOG and CD133) in normal, hyperplastic, and malignant endometrium.
Al-Kaabi M; Noel K; Al-Rubai AJ
J Med Life; 2022 Jan; 15(1):117-123. PubMed ID: 35186145
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
7. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
8. PAX2 loss by immunohistochemistry occurs early and often in endometrial hyperplasia.
Allison KH; Upson K; Reed SD; Jordan CD; Newton KM; Doherty J; Swisher EM; Garcia RL
Int J Gynecol Pathol; 2012 Mar; 31(2):151-159. PubMed ID: 22317873
[TBL] [Abstract][Full Text] [Related]
9. Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium.
Kim KH; Choi JS; Kim JM; Choi YL; Shin YK; Lee HC; Seong IO; Kim BK; Chae SW; Kim SH
Histol Histopathol; 2009 Mar; 24(3):309-16. PubMed ID: 19130400
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
[TBL] [Abstract][Full Text] [Related]
11. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
12. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
13. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
14. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
15. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
16. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
17. FHIT expression in neoplastic, hyperplastic, and normal endometrium.
Ozkara SK; Corakçi A
Int J Gynecol Cancer; 2005; 15(6):1081-8. PubMed ID: 16343185
[TBL] [Abstract][Full Text] [Related]
18. Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications.
Orlandi A; Ferlosio A; Ciucci A; Sesti F; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
Histopathology; 2004 Nov; 45(5):511-7. PubMed ID: 15500655
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1).
Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Stefanaki S; Makrydimas G; Agnantis NJ
Eur J Gynaecol Oncol; 2003; 24(6):500-4. PubMed ID: 14658589
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]